...
首页> 外文期刊>Marine biotechnology >Immunomodulatory effects of an enzymatic extract from Ecklonia cava on murine splenocytes
【24h】

Immunomodulatory effects of an enzymatic extract from Ecklonia cava on murine splenocytes

机译:Ecklonia cava酶提取物对小鼠脾细胞的免疫调节作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We investigated whether the brown seaweed Alariaceae Ecklonia cava (E. cava) has immunological effects on splenocytes in vitro. For that purpose, we prepared an enzymatic extract from E. cava (ECK) by using the protease, Kojizyme. Here, ECK administered to ICR mice dramatically enhanced the proliferation of their splenocytes and increased the number of their lymphocytes, monocytes and granulocytes. In flow cytometry assays performed to identify in detail the specific phenotypes of these proliferating cells after ECK treatment, the numbers of CD4(+) T cells, CD8(+) T cells and CD45R/B220(+) B cells increased significantly compared to those in untreated controls. In addition, the mRNA expression and production level of Th1-type cytokines, i.e., TNF-alpha and IFN-gamma, were down-regulated, whereas those of Th2-type cytokines, i.e., IL-4 and IL-10, were up-regulated by ECK. Overall, this dramatic increase in numbers of splenocytes indicated that ECK could induce these cells to proliferate and could regulate the production of Th1- as well as Th2-type cytokines in immune cells. These results suggest that ECK has the immunomodulatory ability to activate the anti-inflammatory response and/or suppress the proinflammatory response, thereby endorsing its usefulness as therapy for diseases of the immune system.
机译:我们调查了棕色海藻Alariaceae Ecklonia cava(E. cava)在体外对脾细胞是否具有免疫学作用。为此,我们使用蛋白酶Kojizyme从大肠杆菌(ECK)制备了酶提取物。在这里,给予ICR小鼠的ECK极大地增强了它们的脾细胞的增殖,并增加了它们的淋巴细胞,单核细胞和粒细胞的数量。在进行流式细胞术分析以详细确定这些增殖细胞在ECK处理后的具体表型后,与那些相比,CD4(+)T细胞,CD8(+)T细胞和CD45R / B220(+)B细胞的数量明显增加。在未经处理的对照中。此外,Th1型细胞因子即TNF-α和IFN-γ的mRNA表达和生产水平被下调,而Th2型细胞因子即IL-4和IL-10的mRNA表达和生产水平被上调。 -由ECK监管。总体而言,脾细胞数量的急剧增加表明ECK可以诱导这些细胞增殖,并可以调节免疫细胞中Th1以及Th2型细胞因子的产生。这些结果表明ECK具有激活抗炎反应和/或抑制促炎反应的免疫调节能力,从而认可其作为用于免疫系统疾病的疗法的有用性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号